Generate:Biomedicines and Roswell Park Comprehensive Cancer Center Enter into a Collaboration Agreement to Accelerate Novel Cell Therapies for Oncology Using Generative AI

SOMERVILLE, Mass., & BUFFALO, N.Y.--(BUSINESS WIRE)--Generate:Biomedicines and Roswell Park Comprehensive Cancer Center today announced a strategic collaboration to discover and develop chimeric antigen receptor (CAR) T-cell therapies, and armoring technologies, for up to three oncology targets, including in ovarian cancer and other solid tumors. In ovarian cancer alone, an estimated 314,000 women worldwide are diagnosed and over 200,000 women die each year. Under the collaboration agreement, G